Trademarkia Logo

Australia

AU$
Trademark Search
T2D

View On IPO.GOV.AU

T2D
Lapsed: Not accepted

Last updated on 31 Aug 2017

Owner Info

Intarcia Therapeutics, Inc. a Delaware corporation

One Marina Park Drive

Suite 1300, UNITED STATES OF AMERICA

Serial Number

1745848 filed on 12 Jan 2016

Correspondent

Davies Collison Cave Pty Ltd

Level 4,

7 Macquarie Place,

Sydney, NSW, 2000 AUSTRALIA

T2D

Classification Information

Class [005]
Pharmaceutical preparations for the treatment of diabetes, obesity and metabolic diseases/disorders

Class [010]
Drug delivery systems; medical apparatus for the administration of pharmaceuticals; medical apparatus for treatment of diabetes, obesity and metabolic Read More

Class [041]
Development and dissemination of educational materials of others in the fields of diabetes, obesity, metabolic diseases/disorders, drug delivery techn Read More

Class [042]
Research and development of pharmaceutical preparations, products and technology in the fields of diabetes, obesity, metabolic diseases/disorders, dru Read More

Class [044]
Medical information services, namely, providing information on the topics of diabetes, obesity, and metabolic diseases/disorders and the diagnosis, tr Read More

Mark Details

Serial Number

1745848

Registered On

NA

Renewal On

NA

Mark Type

FANCY

Priority Claim (Convention Details)

Date

17 Jul 2015

Mark Type

US

Legal History

Show more

Status DateAction Taken
31st Aug 2017IP Right Lapsed Published
25th Aug 2017Application Status
12th May 2017Extend Acceptance Date
11th May 2017Application Status
11th May 2017Extension of time
28th Apr 2017Approve Further Adverse Report
28th Apr 2017User Created Notice correspondence sent
28th Apr 2017Adverse Report correspondence sent
7th Apr 2017Exam Response
14th Mar 2017No Response to 1st Report Within 12 Months Reminder correspondence sent